Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Lymphoma 23Lymphoma, Non-Hodgkin 22Lymphoma, Large B-Cell, Diffuse 16Hodgkin Disease 16Lymphoma, Mantle-Cell 13Lymphoma, Follicular 13Burkitt Lymphoma 9Multiple Myeloma 7Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, B-Cell 6Glioblastoma 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Gliosarcoma 4Glioma 4Recurrence 3Neoplasms, Plasma Cell 3Neoplasms 3Leukemia, Myeloid, Acute 3Congenital Abnormalities 3Astrocytoma 3Waldenstrom Macroglobulinemia 2Primary Myelofibrosis 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Myelodysplastic Syndromes 2

Interventions

fludarabine phosphate 12Mycophenolic Acid 12Cyclophosphamide 11Whole-Body Irradiation 10Cyclosporine 10Cord Blood Stem Cell Transplantation 9Peripheral Blood Stem Cell Transplantation 7Busulfan 6Tacrolimus 5Radiotherapy 5fludarabine 4Antilymphocyte Serum 4Thiotepa 3Methotrexate 3Melphalan 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Cyclosporins 3sargramostim 2merphos 2Methylprednisolone 2Decitabine 2Cytarabine 2vatalanib 1poly ICLC 1lintuzumab 1entinostat 1Vorinostat 1Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anemia, Refractory × Carmustine × Clear all
NCT00281879 2017-09-27

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

OHSU Knight Cancer Institute

Phase 2 Terminated
200 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡